MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress » Clinical Trials and Therapy in Movement Disorders (non-PD) (non-Dystonia)

Meeting: 2023 International Congress

A multiple-dose thorough QT study to evaluate the effect of ampreloxetine on cardiac repolarization in healthy subjects

M. Borin, J. Kanodia, R. Graham, A. Lo, B. Zheng, D. Bourdet (South San Francisco, USA)

A randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa/levodopa in patients with Parkinson’s disease

J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

An Analysis of Subgroups of Multiple System Atrophy Patients from Ampreloxetine Phase 3 Trials

R. Freeman, I. Biaggioni, L. Norcliffe-Kaufmann, T. Guerin, R. Vickery, L. Manzanares, V. Iodice, M. Rudzińska-Bar, M. Pellecchia, H. Kaufmann (Boston, USA)

Baseline characteristics for patients with multiple system atrophy entering a randomized, controlled study of the anti-α-synuclein monoclonal antibody Lu AF82422

W. Singer, A. Takeda, L. Kjærsgaard, J. Wiedemann, A. Berger, A. Varrone, A. Bidani, D. Meulien (Rochester, USA)

Brain-behavior quantification and synchronization to drive closed-loop deep brain stimulation

A. Gunduz, D. Johnson, M. Okun, K. Foote (Gainesville, USA)

Circuit-based targeting for closed-loop deep brain stimulation for Tourette Syndrome

C. Butson, A. Gunduz, K. Foote, E. Mahoney-Rafferty, J. Gomez, M. Hook, J. Cagle, G. Lowor, U. Suryadevara, D. Bowers, I. Malaty, W. Allen, M. Okun (Gainesville, USA)

Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)

Effectiveness of at home, repeated transcranial pulse current stimulation (tPCS) sessions for treatment of neurodegenerative ataxia.

G. Prado- Miranda, D. Aur, D. Babiker, M. Jog (London, On, Canada)

Effects of mirror therapy on walking ability in patients with chronic stroke: a randomized controlled study

W H. Weng, R Y. Wang, Y R. Yang (Taipei, Taiwan)

Effects of sling exercise in people with chronic stroke – the emphasis of core muscle control on gait

CY. Chiu, RY. Wang, WC. Chen (Taipei City, Taiwan)

Efficacy and safety of Mexiletine versus Placebo in patients with myotonia: A Systematic Review and Meta-analysis

A. Elettreby, A. Abo Elnaga, M. Alsaied (Mansoura, Egypt)

Efficacy of perampanel in paroxysmal kinesigenic dyskinesia

Z. Li, X. Huang, L. Cao (Shanghai, China)

KINETIC 2: An ongoing phase 2b, randomized, dose-response study of SAGE-324/BIIB124 for the treatment of essential tremor

R. Pahwa, A. Ellenbogen, D. Arkilo, T. Dam, T. Lieu, B. Hersh, M. Qin, S. Garafola, M. Gerbasi, H. Colquhoun (Kansas City, KS, USA)

Safety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa/levodopa-treated patients with Parkinson’s disease: A phase 2a, double-blind, placebo-controlled study

J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

SpeechATAX: A rater blinded randomized controlled trial of intensive home-based biofeedback therapy for dysarthria in progressive ataxia

A. Vogel, L. Graf, H. Reece, M. Magee, V. Soo, S. Braat, E. Petit, S. Borel, A. Durr, R. Roxburgh, M. Synofzik (Melbourne, Australia)

« View all sessions from the 2023 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley